Humacyte, Inc.
- HUMA
- NASDAQ
- Biotechnology
- Bioengineered Tissues
- Regenerative Medicine
$0.43
Today −2.39%Quote Oct 16, 2026, 08:00 PM UTC
−25.40%over the last month
Max drawdown −40.0%From 1-month high −27.3%3 months −34.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$119.2M
Quote Oct 16
Next earnings
Nov 11
Expected, not confirmed
Analyst target
$1.50
+249.7% from here
Floor
$0.36
16.8% below price
Where the price sits
11 analysts
Analyst range, low to high
$1.00$2.00
- Price $0.43
- Resistance $0.44
- Consensus $1.50
The price is right under resistance. Analysts' average target sits about 250% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about HUMAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
184
Founded
2004